LUCIANA Veloso da COSTA

Dr. LUCIANA Veloso da COSTA

Bio-Manguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2025 in Infection and Drug Resistance
Verified
Journal Article
Open access
PSPaula de Souza
Paula de Souza
JRJuliana Ramos
Juliana Ramos
LVLuiza Vasconcellos
Luiza Vasconcellos
LCLUCIANA Veloso da COSTA
LUCIANA Veloso da COSTA
SFStephen Forsythe
Stephen Forsythe
MBMarcelo Lima Brandão
Marcelo Lima Brandão
Antimicrobial resistance (AMR) poses one of the greatest global health challenges, particularly in healthcare-associated infections caused by multidrug-resistant Gram-negative bacilli. Rapid and reliable identification of these pathogens is critical to guide therapy, improve patient outcomes, and support infection control measures. This review explores the application of 16S ribosomal RNA (rRNA) gene sequencing for the identification of pathogenic Gram-negative bacilli included in the World Health Organization (WHO) antimicrobial resistance priority list. The 16S rRNA gene, with its conserved and hypervariable regions, provides a robust molecular marker widely used in bacterial taxonomy and clinical diagnostics. The analysis covers conventional Sanger sequencing, next-generation sequencing (NGS), and third-generation approaches, outlining their advantages, limitations, and clinical applicability. Results indicate that while 16S rRNA sequencing is a valuable tool for genus-level identification, comparative analysis reveals its resolution is often insufficient for distinguishing closely related species such as Escherichia coli and Shigella spp. or for taxa with low interspecies variability. In these cases, complementary strategies – such as multilocus sequence analysis, whole genome sequencing, or advanced mass spectrometry-based methods – are required to achieve accurate identification. Furthermore, the reliability of 16S-based identification depends heavily on the quality of reference databases, as demonstrated by in silico analysis of type strains, and adherence to interpretative guidelines. In conclusion, 16S rRNA sequencing remains a cornerstone of molecular diagnostics and epidemiological surveillance of multidrug-resistant Gram-negative pathogens, but its integration with additional molecular and proteomic tools is essential to overcome its limitations and strengthen infection management strategies.

21 January 2022 in Journal of Microbiological Methods
Verified
Journal Article
Closed access
LCLUCIANA Veloso da COSTA
LUCIANA Veloso da COSTA
RMRebeca Vitoria da Silva Lage de Miranda
Rebeca Vitoria da Silva Lage de Miranda
EFErica Louro da Fonseca
Erica Louro da Fonseca
NGNatalia Pedra Gonçalves
Natalia Pedra Gonçalves
CRCristhiane Moura Falavina dos Reis
Cristhiane Moura Falavina dos Reis
VVVerônica Viana Vieira
Verônica Viana Vieira

3 April 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
NCNathalia Gonçalves Santos Caldeira
Nathalia Gonçalves Santos Caldeira
MSMaria Luiza Soares De Souza
Maria Luiza Soares De Souza
RMRebeca Vitória da Silva Lage de Miranda
Rebeca Vitória da Silva Lage de Miranda
LCLUCIANA Veloso da COSTA
LUCIANA Veloso da COSTA
SFStephen Forsythe
Stephen Forsythe
MBMarcelo Lima Brandão
Marcelo Lima Brandão
Bacillus and related genera are among the most important contaminants in the pharmaceutical production environment, and the identification of these microorganisms at the species level assists in the investigation of sources of contamination and in preventive and corrective decision making. The aim of this study was to evaluate three methodologies for the characterization of endospore-forming aerobic bacterial strains isolated from a pharmaceutical unit in Rio de Janeiro, Brazil. MALDI-TOF MS was performed using MALDI Biotyper® and VITEK® MS RUO systems, and complete 16S rRNA gene sequencing was performed using the Sanger methodology. The results showed the prevalence of the genera Bacillus (n = 9; 36.0%), Priestia (n = 5; 20.0%), and Paenibacillus (n = 4; 16.0%). Three (20.0%) strains showed <98.7% of DNA sequencing similarity on the EzBioCloud Database, indicating possible new species. In addition, the reclassification of Bacillus pseudoflexus to the genus Priestia as Priestia pseudoflexus sp. nov. is proposed. In conclusion, 16S rRNA and MALDI TOF/MS were not sufficient to identify all strains at the species level, and complementary analyses were necessary.

7 July 2025 in DNA
Verified
Journal Article
Open access
PDF file
JRJuliana Nunes Ramos
Juliana Nunes Ramos
LCLUCIANA Veloso da COSTA
LUCIANA Veloso da COSTA
VVVerônica Viana Vieira
Verônica Viana Vieira
MBMarcelo Lima Brandão
Marcelo Lima Brandão
Microbial contamination is a critical challenge for the pharmaceutical industry, especially in thermosensitive sterile products, and can compromise their quality and safety. The accurate identification of microorganisms is essential to trace sources of contamination and adopt corrective measures. Although MALDI-TOF MS technology has revolutionized this process, its database limitations necessitate the use of complementary methods, such as sequencing 16S rRNA genes, housekeeping genes, and, in some cases, the entire genome. Advances in sequencing have expanded genomic taxonomy, increasing the accuracy of bacterial identification. The integration of these approaches significantly improves the reliability of identification, overcoming the limitations of isolated methods.

1 August 2022 in Letters in Applied Microbiology
Verified
Journal Article
Closed access
LBL.M.P.S. Braga
L.M.P.S. Braga
BSB.A.A. Saad
B.A.A. Saad
COC.T.F. de Oliveira
C.T.F. de Oliveira
CVC.E. Volpe-Chaves
C.E. Volpe-Chaves
MLM.L.G.G. Lacerda
M.L.G.G. Lacerda
MBMarcelo Lima Brandão
Marcelo Lima Brandão

29 August 2024 in Life
Verified
Journal Article
Open access
PDF file
PSPaula Araujo Souza
Paula Araujo Souza
MSMilena Santos
Milena Santos
RMRebeca Vitória da Silva Lage de Miranda
Rebeca Vitória da Silva Lage de Miranda
LCLUCIANA Veloso da COSTA
LUCIANA Veloso da COSTA
RPRaphael Paschoal
Raphael Paschoal
MBMarcelo Lima Brandão
Marcelo Lima Brandão
This study aimed to characterize Pseudomonas aeruginosa strains isolated from hospitalized patients during the COVID-19 pandemic. This was achieved using phenotypic and molecular techniques, including their antimicrobial resistance profile and biofilm formation. Eighteen strains were isolated from a hospital in Rio de Janeiro, Brazil, and identified by VITEK®2, MALDI-TOF/MS (VITEK MS® and MALDI Biotyper®), and 16S rRNA sequencing. Fourier-transform infrared (FTIR) spectroscopy, antimicrobial susceptibility testing, and biofilm formation and disinfectant tolerance tests were applied to evaluate the virulence characteristics of the strains. VITEK®2 (≥99%), VITEK MS® (≥82.7%), and MALDI Biotyper® (score ≥ 2.01) accurately identified the P. aeruginosa strains, but 16S rRNA sequencing did not differentiate the species P. aeruginosa from P. paraeruginosa. FTIR typing identified three different clusters, but no correlation between the phenotypical or antimicrobial susceptibility testing patterns was found. Most strains exhibited resistance to various antimicrobials. The exceptions were sensitivity to amikacin and norfloxacin, and consequently, these could be considered potential treatment options. Most strains (n = 15, 83.3%) produced biofilms on polystyrene. Sodium hypochlorite treatment (0.5%/15 min) was shown to be the most effective disinfectant for biofilm elimination. P. aeruginosa biofilm formation and tolerance to disinfectants demonstrate the need for effective cleaning protocols to eliminate contamination by this organism in the hospital environment and medical equipment.